PRAX (Praxis Precision Medicines) FCF Margin % : -752.00% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Praxis Precision Medicines FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Praxis Precision Medicines's Free Cash Flow for the three months ended in Dec. 2024 was $-56.12 Mil. Praxis Precision Medicines's Revenue for the three months ended in Dec. 2024 was $7.46 Mil. Therefore, Praxis Precision Medicines's FCF Margin % for the quarter that ended in Dec. 2024 was -752.00%.

As of today, Praxis Precision Medicines's current FCF Yield % is -17.58%.

The historical rank and industry rank for Praxis Precision Medicines's FCF Margin % or its related term are showing as below:

PRAX' s FCF Margin % Range Over the Past 10 Years
Min: -4543.77 Med: -3042.13 Max: -1540.48
Current: -1540.48

During the past 7 years, the highest FCF Margin % of Praxis Precision Medicines was -1540.48%. The lowest was -4543.77%. And the median was -3042.13%.

PRAX's FCF Margin % is ranked worse than
80.63% of 1012 companies
in the Biotechnology industry
Industry Median: -131.635 vs PRAX: -1540.48

Praxis Precision Medicines FCF Margin % Historical Data

The historical data trend for Praxis Precision Medicines's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxis Precision Medicines FCF Margin % Chart

Praxis Precision Medicines Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-4,543.77

-1,540.48

Praxis Precision Medicines Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-4,633.20	-4,839.21	-7,640.90	-9,105.96	-752.00

Competitive Comparison of Praxis Precision Medicines's FCF Margin %

For the Biotechnology subindustry, Praxis Precision Medicines's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Praxis Precision Medicines's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Praxis Precision Medicines's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Praxis Precision Medicines's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Praxis Precision Medicines FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Praxis Precision Medicines's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-131.757	/	8.553
	=	-1,540.48 %

Praxis Precision Medicines's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-56.122	/	7.463
	=	-752.00 %

Praxis Precision Medicines FCF Margin % Related Terms

Thank you for viewing the detailed overview of Praxis Precision Medicines's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Praxis Precision Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Praxis Precision Medicines Inc (NAS:PRAX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 High Street, 30th Floor, Boston, MA, USA, 02110

Website

https://www.praxismedicines.com

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Executives

Alex Nemiroff	officer: General Counsel and Secretary	C/O PRAXIS PRECISION MEDICINES, INC., ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Lauren Mastrocola	officer: Principal Accounting Officer	C/O PRAXIS PRECISION MEDICINES, INC., ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Jill Desimone	director	C/O PRAXIS PRECISION MEDICINES, INC., 99 HIGH STREET, 30TH FLOOR, BOSTON MA 02110
Marcio Souza	officer: Chief Executive Officer	C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD NJ 07080
Dean J Mitchell	director	C/O BRISTOL MYERS SQUIBB CO, 345 PARK AVE, NEW YORK NY 10164
Timothy Edwin Kelly	officer: Chief Financial Officer	C/O PRAXIS PRECISION MEDICINES, INC., ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Bsof Parallel Master Fund L.p.	10 percent owner	345 PARK AVENUE, NEW YORK NY 10154
Merit Ester Cudkowicz	director	C/O PRAXIS PRECISION MEDICINES, INC., ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Jeffrey Chodakewitz	director	C/O TETRAPHASE PHARMACEUTICALS, INC., 480 ARSENAL ST., SUITE 101, WATERTOWN MA 02472
Stefan Vitorovic	director	C/O PRAXIS PRECISION MEDICINES, INC., ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Blackstone Holdings I/ii Gp L.l.c.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
William D Young	director	901 GATEWAY BLVD, SOUTH SAN FRANCISCO CA 94080
Stephen A Schwarzman	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Inc.	10 percent owner	345 PARK AVENUE, NEW YORK NY 10154
Blackstone Group Management L.l.c.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154